STEMPOINT CAPITAL LP - 31 Dec 2025 SCHEDULE 13G/A Report for Xilio Therapeutics, Inc. Common stock, par value $0.0001 per share (XLO)

Filing Manager
STEMPOINT CAPITAL LP
Reporting Manager
StemPoint Capital LP
Security
Xilio Therapeutics, Inc. Common stock, par value $0.0001 per share
Symbol
XLO
Shares outstanding
71,786,048 shares
Disclosed Ownership
6,030,028 shares
Ownership
8.4%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 10:00:09 UTC
Date of event
31 Dec 2025
Previous filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
StemPoint Capital LP 8.4% 6,030,028 0 6,030,028 /s/ Sean C. Tan Sean C. Tan, Authorized Signatory
StemPoint Capital Management GP LLC 8.4% 6,030,028 0 6,030,028 /s/ Sean C. Tan Sean C. Tan, Authorized Signatory
Michelle Ross 8.4% 6,030,028 0 6,030,028 /s/ Michelle Ross Michelle Ross